login
login
Image header Agence Europe
Europe Daily Bulletin No. 13039
Contents Publication in full By article 26 / 37
ECONOMY - FINANCE - BUSINESS / Competition

Statement of objections sent to Teva concerning practices delaying competition for Copaxone

The European Commission informed Teva on Monday 10 October of its preliminary view that the company had breached EU rules on anti-competitive behaviour by engaging in practices designed to delay competition for its medicine Copaxone.

These practices consisted of an artificial extension of the patent protection of Copaxone and the systematic dissemination of misleading information about a competing product in order to hinder its market entry and uptake.

Teva’s blockbuster medicine...

Contents

SECTORAL POLICIES
Russian invasion of Ukraine
EXTERNAL ACTION
SOCIAL - CULTURE
ECONOMY - FINANCE - BUSINESS
COUNCIL OF EUROPE
NEWS BRIEFS